We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Hunch, known as Hunch Sports Limited, has recognized a potential to create and offer a user-friendly software platform designed to offer a variety of socially interactive prediction games for both sports enthusiasts (B2C) and brands (B2B).
days to go: Expired investment: Withheld
Lightpoint Medical is a technology company that is a pioneer in developing and marketing precision-guided cancer surgery. Surgeons aren't able to see if the cancerous tissue has been removed in its entirety or not during a surgery. To better this situation, the company has developed an imaging technology based on PET radiopharmaceuticals, more precisely, Cerenkov Luminescence Imaging (CLI), which helps surgeons to detect cancer in a real-time during surgery. The company's first product has received marketing authorisation, i.e., the CE (European Conformity) Mark. A second product, a laparoscopic device for prostate cancer is in development. A non-clinical device has also been released. For its efforts, Lightpoint Medical won the 'Best in Show' Award at the 2014 MedTech Investing Europe Conference. The company aims to utilise the investment to scale its business.
days to go: Expired investment: Withheld
A medical condition management platform allowing clinicians to create their own app to improve a patient's health whilst reducing costs. Living With develops smart apps specific to a person's condition, they currently have 3 products with another in the development stage. Their primary app, Squeezy, is the top paid medical app in the UK that helps patients with their pelvic floor exercises. Other apps, allow clinicians to monitor a patient's bowel and bladder health, as well as those with rheumatoid arthritis. These apps are already in use at multiple NHS Trusts and clinics. Funds are being raised to complete development of their apps to help those with lupus and lung cancer, in addition to further developing their existing products. The company aims to have thousands of apps that will be available worldwide to provide self-service treatment at any time. Living With is expecting to earn £1.07m in revenue by the end of March 2019.
days to go: Expired investment: £250,000
Market Porter is a food-tech platform connecting independant food producers, such as butchers and farm shops, with the consumers. The company are the only food-tech platform which work on a national scale instead of just locally. They source out the best small scale producers with top quality and taste, all delivered straight to your door. 
days to go: Expired investment: £885,000
Walljam is a sports technology business that is digitising ball sports through its advanced, smart panel technology. The company's latest offering, 'Metrix', is the first football-themed social entertainment venue launched in partnership with UEFA Champions League. Walljam intends Metrix to be the turning point in the company's image from a purely fan engagement platform to a social entertainment and live events operator. Metrix's inaugural venue will open in Autumn 2020 at Westfield London (White City), Europe’s largest shopping mall. Under the UEFA Global Licensing Partnership, nine more venues are expected to open across Europe within the next five years. The company is seeking to raise funds of £3.5 million at a pre-money valuation of £3.6 million. It will use the investment to launch the first Metrix venue and manage working capital.
days to go: Expired investment: £577,132
Netflix, Inc. is an American media service provider and production company founded in 1997 by Reed Hastings and Marc Randolph in Scotts Valley, California. It has 100 million members in over 190 countries enjoying more than 125 million hours of TV programmes and films per day. In 2017, the company's project 'The White Helmets' won the Academy Award for Best Documentary (Short Subject). For the fiscal year 2019, the company's annual net income was $1.9 billion, up 54.1% Year-over-Year (YOY). The company has won a list of accolades such as the Academy Awards, Golden Globe Awards, BAFTA Film Awards, Grammy Awards, and Daytime Emmy Awards, to name a few. It will use the investment to grow its business across different verticals. 
days to go: Expired investment: £844,200
Oh You Pretty Things Limited are a chain of Champagne and cocktail bars specifically designed for regional department stores and shopping centres. They serve indulgent treats, champagne, cocktails and coffee in stunning bars across the UK such as Manchester, Gateshead, Leeds and Essex. They have also signed a concession agreement to roll out 11 bars within a major UK retailer and will be opening the first on Oxford Street in April 2017.
days to go: Expired investment: £693,000
Ombar is re-defining chocolate by making premium chocolate bars from unroasted raw cacao and other natural, healthy ingredients.
days to go: Expired investment: £354,000
Orthogem is a UK based manufacturer of synthetic bone grafts. Synthetic bone grafts are substitutes for human bone grafts and are designed to replace bone that has been lost. Orthogem have recently started to produce their product in a putty form in order to keep up with the changes in the market. 
days to go: Expired investment: £722,784
Oxford Nanoimaging (ONI) is an offshoot company, born from the biological physics lab at Oxford University, that specialises in super-resolution microscopy. Its innovation, Nanoimager, is a super-resolution fluorescence and portable microscope that is capable of real-time 3D localization analysis and rendering. It has multiple applications in a variety of fields such as viral particle imaging, quantitative cellular imaging, epigenetic mapping, and many more. ONI states that the Nanoimager can align and analyse samples, and then upload the results onto a computer for deeper graphical and data examination. ONI is also supporting the global effort into research and diagnostics to tackle the COVID-19 pandemic and finds the Nanoimager uniquely suited to this task. The company plans to use the investment to grow its business and ensure more institutions and researchers adopt its technology.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph